Comparison of stimulating effect on subpopulations of lymphocytes in human peripheral blood by methionine enkephalin with IL-2 and IFN-γ

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 8, 2012, Pages 1082-1089

  Hua, Hui ^a   Lu, Changlong ^a   Li, Weiwei ^a   Meng, Jingjuan ^a   Wang, Danan ^a   Plotnikoff, Nicolas P ^b   Wang, Enhua ^a   Shan, Fengping ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b TNI Biotech Inc   (United States)

Author keywords

Human peripheral blood; Interferon ; Interleukin 2; Lymphocyte subpopulations; Methionine enkephalin

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; MESSENGER RNA; METENKEPHALIN;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; COMPARATIVE STUDY; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPHENOTYPING; IN VITRO STUDY; NATURAL KILLER CELL; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; CELLS, CULTURED; ENKEPHALIN, METHIONINE; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; INTERLEUKIN-2; LYMPHOCYTE SUBSETS; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84866060748     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.20759     Document Type: Article

References (41)

1. Bhargava HN. Opioid peptides, receptors, and immune function. NIDA Res Monogr 1990; 96:220-33; PMID:2172824.
2. Plotnikoff NP. Methionine enkephalin: a new cytokine-human studies. J Clin Immunol Immunopathol 1997; 82:93-101; http://dx.doi.org/10.1006/clin.1996. 4287.
3. Ohmori H, Fujii K, Sasahira T, Luo Y, Isobe M, Tatsumoto N, et al. Methionine-enkephalin secreted by human colorectal cancer cells suppresses T lymphocytes. Cancer Sci 2009; 100:497-502; PMID:19141128; http://dx.doi.org/10. 1111/j.1349-7006.2008.01073.x.
4. Hsueh CM, Chen SF, Huang HJ, Ghanta VK, Hiramoto RN. Activation of mu-opioid receptors are required for the conditioned enhancement of NK cell activity. Brain Res 1996; 737:263-8; PMID:8930374; http://dx.doi.org/10.1016/ 0006-8993(96)00740-8.
5. Burger RA, Warren RP, Huffman JH, Sidwell RW. Effect of methionine enkephalin on natural killer cell and cytotoxic T lymphocyte activity in mice infected with influenza A virus. Immunopharmacol Immunotoxicol 1995; 17:323-34; PMID:7650294; http://dx.doi.org/10.3109/08923979509019754.
6. Kowalski J, Belowski D, Wielgus J. Bidirectional modulation of mouse natural killer cell and macrophage cytotoxic activities by enkephalins. Pol J Pharmacol 1995; 47:327-31; PMID:8616512.
7. Mosnaim AD, Wolf ME, Maturana P, Mosnaim G, Puente J, Kucuk O, et al. In vitro studies of natural killer cell activity in post traumatic stress disorder patients. Response to methionine-enkephalin challenge. Immunopharmacology 1993; 25:107-16; PMID:8500983; http://dx.doi.org/10.1016/0162-3109(93)90014-H.
8. Stanojević S, Mitić K, Vujić V, Kovacević- Jovanović V, Dimitrijević M. The influence of stress and methionineenkephalin on macrophage functions in two inbred rat strains. Life Sci 2007; 80:901-9; PMID:17157881; http://dx.doi.org/10.1016/j.lfs.2006.11.019.
9. Vujić V, Stanojević S, Dimitrijević M. Methionineenkephalin stimulates hydrogen peroxide and nitric oxide production in rat peritoneal macrophages: interaction of mu, delta and kappa opioid receptors. Neuroimmunomodulation 2004; 11:392-403; PMID:15467355; http://dx.doi.org/10.1159/000080150.
10. Esche C, Makarenkova VP, Kost NV, Lotze MT, Zozulya AA, Shurin MR. Murine dendritic cells express functional delta-type opioid receptors. Ann N Y Acad Sci 1999; 885:387-90; PMID:10816671; http://dx.doi.org/10.1111/j.1749-6632.1999. tb08695.x.
11. Makarenkova VP, Esche C, Kost NV, Shurin GV, Rabin BS, Zozulya AA, et al. Identification of delta-and mu-type opioid receptors on human and murine dendritic cells. J Neuroimmunol 2001; 117:68-77; PMID:11431006; http://dx.doi.org/10.1016/S0165-5728(01)00313-7.
12. Bénard A, Boué J, Chapey E, Jaume M, Gomes B, Dietrich G. Delta opioid receptors mediate chemotaxis in bone marrow-derived dendritic cells. J Neuroimmunol 2008; 197:21-8; PMID:18486241; http://dx.doi.org/10.1016/ j.jneuroim.2008.03.020.
13. Shen Z, Reznikoff G, Dranoff G, Rock KL. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 1997; 158:2723-30; PMID:9058806.
14. Shan F, Xia Y, Wang N, Meng J, Lu C, Meng Y, et al. Functional modulation of the pathway between dendritic cells (DCs) and CD4+T cells by the neuropeptide: methionine enkephalin (MENK). Peptides 2011; 32:929-37; PMID:21335041; http://dx.doi.org/10.1016/j.peptides.2011.01.033.
15. Plotnikoff N, Wybran J. Methionine-enkephalin shows promise in reducing HIV in blood. Am Fam Physician 1989; 40:234; PMID:2773759.
16. Marotti T, Gabrilovac J, Rabatic S, Smejkal-Jagar L, Rocic B, Haberstock H. Met-enkephalin modulates stress-induced alterations of the immune response in mice. Pharmacol Biochem Behav 1996; 54:277-84; PMID:8728569; http://dx.doi.org/10.1016/0091-3057(95)02112-4.
17. Kraus J. Regulation of mu-opioid receptors by cytokines. Front Biosci 2009; 1:164-70.
18. Sharp BM. Multiple opioid receptors on immune cells modulate intracellular signaling. Brain Behav Immun 2006; 20:9-14; PMID:16364815; http://dx.doi.org/10.1016/j.bbi.2005.02.002.
19. Sulowska Z, Majewska E, Krawczyk K, Klink M, Tchórzewski H. Influence of opioid peptides on human neutrophil apoptosis and activation in vitro. Mediators Inflamm 2002; 11:245-50; PMID:12396476; http://dx.doi.org/10. 1080/096293502900000104.
20. Menzebach A, Hirsch J, Hempelmann G, Welters ID. Effects of endogenous and synthetic opioid peptides on neutrophil function in vitro. Br J Anaesth 2003; 91:546-50; PMID:14504158; http://dx.doi.org/10.1093/bja/aeg219.
21. Stanojević S, Vujić V, Mitić K, Kustrimović N, Kovacević-Jovanović V, Miletić T, et al. Methionine-enkephalin modulation of hydrogen peroxide (H2O2) release by rat peritoneal macrophages involves different types of opioid receptors. Neuropeptides 2008; 42:147-58; PMID:18237778; http://dx.doi.org/10.1016/j.npep. 2007.12.004.
22. Zagon IS, Donahue RN, Rogosnitzky M, McLaughlin PJ. Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function. Exp Biol Med (Maywood) 2008; 233:968-79; PMID:18480416; http://dx.doi.org/10.3181/0802-RM-58.
23. Hucklebridge FH, Hudspith BN, Lydyard PM, Brostoff J. Stimulation of human peripheral lymphocytes by methionine enkephalin and delta-selective opioid analogues. Immunopharmacology 1990; 19:87-91; PMID:2161808; http://dx.doi.org/10.1016/0162-3109(90)90043-E.
24. Piva M, Moreno JI, Jenkins FS, Smith JK, Thomas JL, Montgomery C, et al. In vitro modulation of cytokine expression by enkephalinderived peptides. Neuroimmunomodulation 2005; 12:339-47; PMID:16557034; http://dx.doi.org/10.1159/ 000091127.
25. Wang D, Meng J, Shan F. Immune system restore on terminal cancer patients by bio-peptide: Methionine Enkephalin(MEK). J Microbiol 2008; 28:39-41.
26. Akbar SM, Furukawa S, Hasebe A, Horiike N, Michitaka K, Onji M. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer. Int J Mol Med 2004; 14:295-9; PMID:15254781.
27. Zagon IS, Verderame MF, Hankins J, McLaughlin PJ. Overexpression of the opioid growth factor receptor potentiates growth inhibition in human pancreatic cancer cells. Int J Oncol 2007; 30:775-83; PMID:17332915.
28. Slominski AT, Zmijewski MA, Zbytek B, Brozyna AA, Granese J, Pisarchik A, et al. Regulated proenkephalin expression in human skin and cultured skin cells. J Invest Dermatol 2011; 131:613-22; PMID:21191404; http://dx.doi.org/10. 1038/jid.2010.376.
29. Cheng F, McLaughlin PJ, Zagon IS. Regulation of cell proliferation by the opioid growth factor receptor is dependent on karyopherin beta and Ran for nucleocytoplasmic trafficking. Exp Biol Med (Maywood) 2010; 235:1093-101; PMID:20705629; http://dx.doi.org/10.1258/ebm.2010.010139.
30. Avella DM, Kimchi ET, Donahue RN, Tagaram HR, McLaughlin PJ, Zagon IS, et al. The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer. Am J Physiol Regul Integr Comp Physiol 2010; 298:R459-66; PMID:19923357; http://dx.doi.org/10.1152/ajpregu. 00646.2009.
31. Gameiro SR, Caballero JA, Higgins JP, Apelian D, Hodge JW. Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses. Cancer Immunol Immunother 2011; 60:1227-42; PMID:21544650; http://dx.doi.org/10. 1007/s00262-011-1020-8.
32. Cany J, Tran L, Gauttier V, Judor JP, Vassaux G, Ferry N, et al. Immunotherapy of hepatocellular carcinoma: is there a place for regulatory T-lymphocyte depletion? Immunotherapy 2011; 3(Suppl):32-4; PMID:21524167; http://dx.doi.org/10.2217/imt.11.29.
33. Lombardi G, Sagoo P, Scotta C, Fazekasova H, Smyth L, Tsang J, et al. Cell therapy to promote transplantation tolerance: a winning strategy? Immunotherapy 2011; 3(Suppl):28-31; PMID:21524166; http://dx.doi.org/10.2217/ imt.11.42.
34. Jing W, Yan X, Hallett WH, et al. Depletion of CD25+ T cells from hematopoietic stem cell grafts increases post-transplant vaccine-induced immunity to neuroblastoma. Blood 2011; 117: 6952-62.
35. Yan M, Jene N, Byrne D, Millar EK, O'Toole SA, McNeil CM, et al. Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basallike breast cancers. Breast Cancer Res 2011; 13:R47; PMID:21521526; http://dx.doi.org/10.1186/ bcr2869.
36. Munn DH. Indoleamine 2,3-dioxygenase, Tregs and cancer. Curr Med Chem 2011; 18:2240-6; PMID:21517755.
37. Schuler PJ, Börger V, Bölke E, Habermehl D, Matuschek C, Wild CA, et al. Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapy. Eur J Med Res 2011; 16:57-62; PMID:21463982; http://dx.doi.org/10.1186/2047-783X-16-2-57.
38. Walczak M, Regts J, van Oosterhout AJ, Boon L, Wilschut J, Nijman HW, et al. Role of regulatory T-cells in immunization strategies involving a recombinant alphavirus vector system. Antivir Ther 2011; 16:207-18; PMID:21447870; http://dx.doi.org/10.3851/IMP1751.
39. McLaughlin PJ, Zagon IS, Park SS, Conway A, Donahue RN, Goldenberg D. Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis. BMC Cancer 2009; 9:369; PMID:19835629; http://dx.doi.org/10.1186/1471-2407-9-369.
40. Kuniyasu H, Luo Y, Fujii K, Sasahira T, Moriwaka Y, Tatsumoto N, et al. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver. Gut 2010; 59:348-56; PMID:19828468; http://dx.doi.org/10.1136/gut.2009.178376.
41. Zagon IS, Donahue RN, McLaughlin PJ. Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers. Am J Physiol Regul Integr Comp Physiol 2009; 297:R1154-61; PMID:19675283; http://dx.doi.org/10.1152/ajpregu.00414.2009.